跳转至内容
Merck
CN

The effect of sonophoresis on topical anesthesia: a pilot project.

Anesthesia progress (2013-06-15)
Joseph L Packer, Barry Krall, Ali Makki, Mahmoud Torabinejad
摘要

The dental anesthesia sonophoresis device (DASD) is a novel device that is intended to reduce the discomfort associated with intraoral mucosa needle puncture. The DASD produces ultrasonic energy that provides a sonophoretic effect on the oral mucosa, generating microchannels through the lipids between the keratinized cells that make up the stratum corneum. Once the topical anesthetic has permeated the stratum corneum, it quickly diffuses through the soft tissue, desensitizing the nerve endings and reducing the perception of pain caused by needle penetration. The aim of this study is to evaluate whether topical anesthesia applied using the DASD will reduce the discomfort of the needle puncture when compared to the control device. A split-mouth model, using 50 healthy subjects with puncture site at the maxillary canine vestibule, was used for this study. Subjects received a needle puncture on both sides of the mouth. Prior to the needle puncture, there was randomized application of 5% lidocaine with the DASD and a control device. Subjects rated their discomfort after needle punctures utilizing the visual analog scale pain scoring system. There was no statistically significant difference in the pain perception using the DASD versus the control device.

材料
产品编号
品牌
产品描述

Supelco
利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
利多卡因, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
利多卡因 盐酸盐 一水合物, solid
Supelco
利多卡因标准液 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
利多卡因, European Pharmacopoeia (EP) Reference Standard
利多卡因, European Pharmacopoeia (EP) Reference Standard